Yandle: An election-year plan to undermine prescription patents is harmful to our health

In a public effort to bring down prescription drug prices, the Biden administration plans to use the government’s “march-in” authority to sever some pharmaceutical drug patent protections. By setting aside

Related Keywords

Washington ,United States ,White House ,District Of Columbia ,American ,Bob Dole ,Birch Bayh ,Lael Brainard ,Department Of Commerce ,National Institutes Of Health ,Washington Post ,National Institutes ,The Economy ,Rade ,Politics ,Harmacology ,Medicine ,Inance ,Jaw ,Industry ,Business ,